Protective effects of dexmedetomidine on cerebral ischemia/reperfusion injury via the microRNA-214/ROCK1/NF-κB axis

Protective effects of dexmedetomidine on cerebral ischemia/reperfusion injury via the microRNA-214/ROCK1/NF-κB axis

Abstract Background Cerebral ischemia/reperfusion injury (CIRI) is a complication of surgical procedure associated with high mortality. The protective effect of dexmedetomidine (DEX) on CIRI has been explored in previous works, yet the underlying molecular mechanism remains unclear. Our study explor...

Full description

Bibliographic Details
Main Authors:	Wenyi Liu, Cuihua Shao, Chuanshan Zang, Jian Sun, Min Xu, Yuna Wang
Format:	Article
Language:	English
Published:	BMC 2021-08-01
Series:	BMC Anesthesiology
Subjects:	Cerebral ischemia/reperfusion injury Dexmedetomidine microRNA-214 Rho-associated kinase 1 NF-κB
Online Access:	https://doi.org/10.1186/s12871-021-01423-5

Similar Items

Decreased miR-214–3p activates NF-κB pathway and aggravates osteoarthritis progression
by: Yumei Cao, et al.
Published: (2021-03-01)

Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway
by: Yiheng Wang, et al.
Published: (2016-06-01)

β-caryophyllene improves cerebral ischemia reperfusion injury in rats via Notch1/NF-κB signal axis
by: LIU Jingdong, et al.
Published: (2021-02-01)

Perineural Dexmedetomidine Attenuates Inflammation in Rat Sciatic Nerve via the NF-κB Pathway
by: Yan Huang, et al.
Published: (2014-03-01)

Lentivirus-mediated overexpression of OTULIN ameliorates microglia activation and neuroinflammation by depressing the activation of the NF-κB signaling pathway in cerebral ischemia/reperfusion rats
by: Hongbei Xu, et al.
Published: (2018-03-01)

Down-Regulation of MicroRNA-214 Contributed to the Enhanced Mitochondrial Transcription Factor A and Inhibited Proliferation of Colorectal Cancer Cells
by: Kaiming Wu, et al.
Published: (2018-08-01)

Effect of dexmedetomidine on acute lung injury in experimental ischemia-reperfusion model
by: Ömer Burak Küçükebe, et al.

The Effects of Dexmedetomidine on Ischemia Reperfusion Injury in Patients Undergoing Arthroscopy Under Spinal Anesthesia
by: Senem Koruk, et al.
Published: (2010-12-01)

Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury via Inhibition of NF-κB Activation and Inflammation in Rats
by: Gaode Zou, et al.
Published: (2021-07-01)

Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis
by: Bing Han, et al.
Published: (2020-01-01)

The preventive effects of dexmedetomidine against intestinal ischemia-reperfusion injury in Wistar rats
by: Xue-kang Zhang, et al.
Published: (2015-06-01)

Physcion Protects Rats Against Cerebral Ischemia-Reperfusion Injury via Inhibition of TLR4/NF-kB Signaling Pathway
by: Dong X, et al.
Published: (2021-01-01)

Ginkgolide C Alleviates Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Inhibition of CD40-NF-κB Pathway
by: Rui Zhang, et al.
Published: (2018-02-01)

Cardioprotection of Ginkgolide B on Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Regulation of A20-NF-κB Pathway
by: Rui Zhang, et al.
Published: (2018-12-01)

Dexmedetomidine preconditioning attenuates ischemia/reperfusion injury in isolated rat hearts with endothelial dysfunction
by: Liang He, et al.
Published: (2019-06-01)

Dexmedetomidine inhibits systemic inflammatory response induced by renal ischemia reperfusion via mediating macrophage polarization
by: HE Xinhai, et al.
Published: (2020-03-01)

Dexmedetomidine protects against lung injury induced by limb ischemia‐reperfusion via the TLR4/MyD88/NF‐κB pathway
by: Bin‐Bin Xue, et al.
Published: (2019-11-01)

Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation
by: Wei Xiong, et al.
Published: (2021-09-01)

Effects and mechanism of dexmedetomidine on neuronal cell injury induced by hypoxia-ischemia
by: Ya-Jun Liu, et al.
Published: (2017-08-01)

Rho protein GTPases and their interactions with NFκB: crossroads of inflammation and matrix biology
by: Louis Tong, et al.
Published: (2014-06-01)

Dexmedetomidine did not reduce the effects of tourniquet-induced ischemia-reperfusion injury during general anesthesia
by: Evrim Bostankolu, et al.
Published: (2013-02-01)

Tisp40 Induces Tubular Epithelial Cell GSDMD-Mediated Pyroptosis in Renal Ischemia-Reperfusion Injury via NF-κB Signaling
by: Chengcheng Xiao, et al.
Published: (2020-08-01)

microRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis
by: Yong Li, et al.
Published: (2021-03-01)

Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?
by: Erkılıç E, et al.
Published: (2017-03-01)

Perioperative Dexmedetomidine attenuates brain ischemia reperfusion injury possibly via up-regulation of astrocyte Connexin 43
by: Xiaoyang Zheng, et al.
Published: (2020-12-01)

HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways
by: Weijie Xie, et al.
Published: (2019-09-01)

Administration of Dexmedetomidine Does Not Produce Long-Term Protective Effect on Testicular Damage Post Testicular Ischemia-Reperfusion Injury
by: Xiao J, et al.
Published: (2021-01-01)

Acupuncture preconditioning protects against myocardial ischemia/reperfusion injury mediated apoptosis through miR-214/NCX1 activation: a hypothesis
by: Hai-Long Fan, et al.
Published: (2019-07-01)

Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats
by: Meral Erdal Erbatur, et al.
Published: (2017-01-01)

Dexmedetomidine protects from post-myocardial ischaemia reperfusion lung damage in diabetic rats
by: Gülay Kip, et al.
Published: (2015-09-01)

Inhibition of heat shock protein family A member 8 attenuates spinal cord ischemia–reperfusion injury via astrocyte NF-κB/NLRP3 inflammasome pathway
by: Jingyi Mi, et al.
Published: (2021-08-01)

Dexmedetomidine Mechanism of Action: an update
by: Sara Salarian, et al.
Published: (2016-03-01)

Dexmedetomidine protects against myocardial ischaemia/reperfusion-induced renal damage in rats
by: Osama M. Assad, et al.
Published: (2018-01-01)

Electroacupuncture Suppresses the NF-κB Signaling Pathway by Upregulating Cylindromatosis to Alleviate Inflammatory Injury in Cerebral Ischemia/Reperfusion Rats
by: Jin Jiang, et al.
Published: (2017-11-01)

Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy
by: Yingying Xiao, et al.
Published: (2021-05-01)

Protection of Anthocyanin from Myrica rubra against Cerebral Ischemia-Reperfusion Injury via Modulation of the TLR4/NF-κB and NLRP3 Pathways
by: Hong-Xin Cui, et al.
Published: (2018-07-01)

Storax Protected Oxygen-Glucose Deprivation/Reoxygenation Induced Primary Astrocyte Injury by Inhibiting NF-κB Activation in vitro
by: Meng Zhang, et al.
Published: (2019-01-01)

Dexmedetomidine attenuates spinal cord ischemia–reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits
by: Zhixiang Sun, et al.
Published: (2018-07-01)

Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway
by: Liang He, et al.
Published: (2021-01-01)

Clusterin Reduces Cold Ischemia-Reperfusion Injury in Heart Transplantation Through Regulation of NF-kB Signaling and Bax/Bcl-xL Expression
by: Guodong Liu, et al.
Published: (2018-02-01)